Article
The promises and challenges of using gene mutations for patient stratification in follicular lymphoma.
Blood - 28 Sept 2017
Weigert Oliver, Weinstock David M
Abstract excerpt
Follicular lymphoma (FL) is a clinically and molecularly highly heterogeneous disease. Most patients achieve long-lasting remissions and have excellent overall survival (OS) with current treatment. However, ∼20% of patients have early progression of disease and short OS. At present, therapies are not guided by individual risk or disease biology. Reliable tools for patient stratification are urgently needed to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
